{{Rsnum
|rsid=1784919
|Gene=SORL1
|Chromosome=11
|position=121568956
|Orientation=minus
|GMAF=0.06107
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SORL1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 3.1 | 96.9
| HCB | 0.0 | 6.7 | 93.3
| JPT | 2.2 | 31.1 | 66.7
| YRI | 4.8 | 17.5 | 77.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 6.7 | 93.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs1784919
|Name_s=
|Gene_s=SORL1
|Feature=
|Evidence=PubMed ID:17553421; PubMed ID:19118814
|Annotation=This variant is nominally associated with late-onset Alzheimer disease (LOAD) in 2 GWAS studies.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363857
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1784919
|overall_frequency_n=103
|overall_frequency_d=120
|overall_frequency=0.858333
|n_genomes=49
|n_genomes_annotated=0
|n_haplomes=85
|n_articles=0
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}